China Resources Double-Crane Pharmaceutical Co.,Ltd. (SHA:600062)
China · Delayed Price · Currency is CNY 18.56
+0.15 (0.81%)
Apr 8, 2026, 3:00 PM CST
SHA:600062 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 1,647 | 1,628 | 1,670 | 1,180 | 935.69 |
Depreciation & Amortization | 776.77 | 755.54 | 690.35 | 561.85 | 467.29 |
Other Amortization | 17.81 | 5.94 | 5.25 | 3.95 | 3.26 |
Loss (Gain) From Sale of Assets | 10.1 | -46.84 | -0.18 | 2.27 | -1.03 |
Asset Writedown & Restructuring Costs | 22.76 | 88.58 | 86.42 | 8.43 | 56.92 |
Loss (Gain) From Sale of Investments | -140.1 | -153.5 | -138.89 | -22.22 | -62.47 |
Provision & Write-off of Bad Debts | 8.58 | -19.12 | 9.19 | 1.49 | 2.47 |
Other Operating Activities | 89.95 | 56.63 | 2.27 | 7.83 | 27.41 |
Change in Accounts Receivable | -590.27 | -443.3 | -537.65 | -232.69 | -130.71 |
Change in Inventory | -11.68 | 71.64 | 309.42 | -33.13 | -384.47 |
Change in Accounts Payable | -267 | -69.23 | -193.44 | -86.31 | 395.5 |
Change in Unearned Revenue | -15.91 | -21.64 | -18.83 | 44.81 | 52.9 |
Change in Other Net Operating Assets | 4.02 | 2.92 | 0.83 | 2.56 | 1.94 |
Operating Cash Flow | 1,490 | 1,825 | 1,859 | 1,416 | 1,341 |
Operating Cash Flow Growth | -18.39% | -1.83% | 31.27% | 5.61% | -1.41% |
Capital Expenditures | -619.63 | -637.5 | -614.31 | -526.6 | -491.67 |
Sale of Property, Plant & Equipment | 103.29 | 57.1 | 3.35 | 3.91 | 11.41 |
Cash Acquisitions | - | - | - | -409.22 | 13.65 |
Divestitures | - | - | - | - | 36.59 |
Investment in Securities | -503.44 | 241.42 | -37.01 | 1,507 | -177.36 |
Other Investing Activities | -26.68 | 1,321 | -135.39 | 17.28 | 37.57 |
Investing Cash Flow | -1,046 | 982.46 | -783.37 | 592.28 | -569.8 |
Long-Term Debt Issued | 154.49 | 1,148 | 15 | 1.45 | 4.75 |
Total Debt Issued | 154.49 | 1,148 | 15 | 1.45 | 4.75 |
Short-Term Debt Repaid | - | - | - | - | -52.44 |
Long-Term Debt Repaid | -206.76 | -255.48 | -39.05 | -32.26 | -21.7 |
Total Debt Repaid | -206.76 | -255.48 | -39.05 | -32.26 | -74.14 |
Net Debt Issued (Repaid) | -52.27 | 892.79 | -24.05 | -30.81 | -69.4 |
Issuance of Common Stock | - | - | - | 144.72 | - |
Repurchase of Common Stock | -1.63 | -5.36 | -1.01 | -290.9 | - |
Common Dividends Paid | -716.05 | -1,479 | -305.89 | -801.76 | -302.59 |
Other Financing Activities | -602.31 | -2,593 | -158.91 | -312.42 | -6.63 |
Financing Cash Flow | -1,372 | -3,185 | -489.85 | -1,291 | -378.62 |
Foreign Exchange Rate Adjustments | -1.14 | 6.94 | 3.69 | 12.28 | 1.3 |
Net Cash Flow | -930.35 | -370.03 | 589.53 | 729.55 | 393.8 |
Free Cash Flow | 869.88 | 1,188 | 1,245 | 889.57 | 849.25 |
Free Cash Flow Growth | -26.75% | -4.59% | 39.93% | 4.75% | -16.09% |
Free Cash Flow Margin | 7.91% | 10.59% | 11.01% | 9.24% | 9.32% |
Free Cash Flow Per Share | 0.84 | 1.16 | 1.22 | 0.86 | 0.81 |
Cash Income Tax Paid | 1,099 | 1,128 | 1,206 | 887.37 | 887.6 |
Levered Free Cash Flow | 150.73 | 1,827 | 1,499 | 202.43 | 309.37 |
Unlevered Free Cash Flow | 171.72 | 1,837 | 1,509 | 209.07 | 316.63 |
Change in Working Capital | -943.31 | -489.83 | -465.74 | -327.49 | -88.62 |
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.